Real-time Estimate
Cboe BZX
10:39:44 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
57.95
USD
|
-1.33%
|
|
+0.96%
|
+5.95%
|
Fiscal Period: September |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
817.7
|
1,215
|
2,808
|
5,420
|
7,660
|
-
|
-
|
Enterprise Value (EV)
1 |
1,455
|
1,660
|
3,702
|
6,228
|
8,400
|
8,315
|
8,183
|
P/E ratio
|
34.6
x
|
43.9
x
|
23.4
x
|
33.5
x
|
34
x
|
28.8
x
|
24.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.83
x
|
0.97
x
|
2.05
x
|
3.25
x
|
3.88
x
|
3.49
x
|
3.13
x
|
EV / Revenue
|
1.47
x
|
1.33
x
|
2.7
x
|
3.74
x
|
4.26
x
|
3.79
x
|
3.35
x
|
EV / EBITDA
|
7.38
x
|
7.1
x
|
13.6
x
|
18.4
x
|
20.1
x
|
18.3
x
|
15.9
x
|
EV / FCF
|
15.3
x
|
7.39
x
|
193
x
|
29.1
x
|
39.2
x
|
29.9
x
|
25.3
x
|
FCF Yield
|
6.53%
|
13.5%
|
0.52%
|
3.43%
|
2.55%
|
3.34%
|
3.95%
|
Price to Book
|
-5.09
x
|
-64.3
x
|
-7.41
x
|
-16.7
x
|
-37.7
x
|
-102
x
|
35.6
x
|
Nbr of stocks (in thousands)
|
39,429
|
39,510
|
136,244
|
131,446
|
130,434
|
-
|
-
|
Reference price
2 |
20.74
|
30.75
|
20.61
|
41.23
|
58.73
|
58.73
|
58.73
|
Announcement Date
|
11/19/20
|
11/18/21
|
11/17/22
|
11/20/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
854.4
|
988.3
|
1,247
|
1,372
|
1,667
|
1,972
|
2,193
|
2,445
|
EBITDA
1 |
198.1
|
197.2
|
233.9
|
271.4
|
338.3
|
417.8
|
454.7
|
513.7
|
EBIT
1 |
169.2
|
165.4
|
172.9
|
239.1
|
295.5
|
371.6
|
411.7
|
470.2
|
Operating Margin
|
19.8%
|
16.74%
|
13.86%
|
17.43%
|
17.73%
|
18.84%
|
18.78%
|
19.23%
|
Earnings before Tax (EBT)
1 |
162.5
|
109.3
|
123.2
|
145.6
|
220.4
|
304.8
|
352.7
|
400.5
|
Net income
1 |
123.1
|
23.5
|
27.6
|
82.3
|
165.5
|
228.9
|
266.3
|
301.3
|
Net margin
|
14.41%
|
2.38%
|
2.21%
|
6%
|
9.93%
|
11.61%
|
12.14%
|
12.32%
|
EPS
2 |
3.120
|
0.6000
|
0.7000
|
0.8800
|
1.230
|
1.729
|
2.038
|
2.396
|
Free Cash Flow
1 |
95.1
|
95.1
|
224.5
|
19.2
|
213.8
|
214.2
|
277.9
|
323.6
|
FCF margin
|
11.13%
|
9.62%
|
18%
|
1.4%
|
12.83%
|
10.86%
|
12.68%
|
13.23%
|
FCF Conversion (EBITDA)
|
48.01%
|
48.23%
|
95.98%
|
7.07%
|
63.2%
|
51.26%
|
61.12%
|
62.99%
|
FCF Conversion (Net income)
|
77.25%
|
404.68%
|
813.41%
|
23.33%
|
129.18%
|
93.56%
|
104.38%
|
107.38%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/21/19
|
11/19/20
|
11/18/21
|
11/17/22
|
11/20/23
|
-
|
-
|
-
|
Fiscal Period: September |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
306.5
|
315.2
|
370.6
|
379.2
|
362.7
|
385.6
|
445.9
|
472.6
|
430.4
|
494.6
|
506.9
|
539.3
|
484.5
|
541.5
|
570.6
|
EBITDA
1 |
59.8
|
50.9
|
80.8
|
79.9
|
84.9
|
68
|
86.9
|
98.5
|
100.5
|
103.7
|
102.9
|
109.4
|
106.7
|
107.9
|
115.9
|
EBIT
1 |
52.5
|
43.4
|
71.8
|
71.4
|
76.1
|
59.2
|
77.9
|
82.3
|
77.9
|
93.6
|
92.66
|
98.92
|
99.41
|
99.01
|
105.3
|
Operating Margin
|
17.13%
|
13.77%
|
19.37%
|
18.83%
|
20.98%
|
15.35%
|
17.47%
|
17.41%
|
18.1%
|
18.92%
|
18.28%
|
18.34%
|
20.52%
|
18.28%
|
18.45%
|
Earnings before Tax (EBT)
1 |
42.2
|
7.1
|
51.6
|
44.7
|
58.5
|
41.2
|
58.7
|
62
|
58.1
|
76.5
|
77.67
|
84.4
|
87.34
|
84.3
|
93.92
|
Net income
1 |
8.2
|
1.3
|
39.1
|
33.7
|
44.2
|
30.9
|
44.3
|
46.1
|
43.9
|
57.2
|
58.32
|
63.37
|
65.91
|
63.63
|
70.91
|
Net margin
|
2.68%
|
0.41%
|
10.55%
|
8.89%
|
12.19%
|
8.01%
|
9.93%
|
9.75%
|
10.2%
|
11.56%
|
11.5%
|
11.75%
|
13.61%
|
11.75%
|
12.43%
|
EPS
2 |
0.2100
|
0.0200
|
0.2900
|
0.2500
|
0.3300
|
0.2300
|
0.3300
|
0.3500
|
0.3300
|
0.4300
|
0.4418
|
0.4819
|
0.4963
|
0.4798
|
0.5374
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/3/22
|
5/5/22
|
8/4/22
|
11/17/22
|
2/6/23
|
5/8/23
|
8/7/23
|
11/20/23
|
2/5/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
638
|
445
|
894
|
808
|
740
|
655
|
522
|
Net Cash position
1 |
5.5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.234
x
|
1.902
x
|
3.293
x
|
2.39
x
|
1.771
x
|
1.441
x
|
1.016
x
|
Free Cash Flow
1 |
95.1
|
95.1
|
225
|
19.2
|
214
|
214
|
278
|
324
|
ROE (net income / shareholders' equity)
|
26.2%
|
61.5%
|
-
|
-
|
-
|
-
|
-
|
855%
|
ROA (Net income/ Total Assets)
|
21.3%
|
25.1%
|
3.96%
|
15.5%
|
23.7%
|
30.5%
|
30.2%
|
30.3%
|
Assets
1 |
577.4
|
93.64
|
696.5
|
530.4
|
699.4
|
751.2
|
880.7
|
993.8
|
Book Value Per Share
2 |
12.30
|
-4.080
|
-0.4800
|
-2.780
|
-2.470
|
-1.560
|
-0.5800
|
1.650
|
Cash Flow per Share
2 |
2.410
|
2.460
|
5.700
|
0.2200
|
1.610
|
1.610
|
2.040
|
2.500
|
Capex
1 |
3.2
|
2.1
|
1.6
|
1.8
|
1.8
|
2.82
|
2
|
2
|
Capex / Sales
|
0.37%
|
0.21%
|
0.13%
|
0.13%
|
0.11%
|
0.14%
|
0.09%
|
0.08%
|
Announcement Date
|
11/21/19
|
11/19/20
|
11/18/21
|
11/17/22
|
11/20/23
|
-
|
-
|
-
|
Last Close Price
58.73
USD Average target price
65.53
USD Spread / Average Target +11.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.95% | 7.66B | | +10.73% | 7.96B | | -0.58% | 5.88B | | -8.26% | 3.72B | | -13.21% | 3.47B | | -15.49% | 1.16B | | -26.05% | 1.12B | | +9.98% | 948M | | -12.18% | 905M | | -12.95% | 831M |
Special Foods & Wellbeing Products
|